RAFAEL HOLDINGS, INC. Gain (Loss) Related to Litigation Settlement
RAFAEL HOLDINGS, INC. (RFL) reported Gain (Loss) Related to Litigation Settlement of $3.50 million for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. gain (loss) related to litigation settlement for the quarter ending 2026-04-30 was $3.50M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 9 month |
|---|---|---|
| 2026-04-30 | $3.50M 10-Q · filed 2026-06-11 | $3.50M 10-Q · filed 2026-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |